SUMO2 Antikörper (C-Term)
Kurzübersicht für SUMO2 Antikörper (C-Term) (ABIN783834)
Target
Alle SUMO2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Affinity chromatography
-
Immunogen
- 15 amino acid peptide near the carboxy terminus of human SUMO2.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
-
- SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))
-
Andere Bezeichnung
- SUMO2
-
Hintergrund
- Small ubiquitin-like modifiers (SUMOs) are a family of small, related proteins (Sumo-1/2/3/4) that can be enzymatically attached to a target protein by a post-translational modification process termed sumoylation, which is a major regulator of protein function in cellular processes such as nuclear transport, transcriptional regulation, apoptosis and protein stability. All SUMO proteins localize to the nucleus and are covalently conjugated, affecting protein structure, function and interactions. SUMO2 and 3 are 96 % identical and are more mobile within nucleus relative to SUMO1. Specific functional differences between SUMO1 and SUMO2 and 3 remain to be identified.Synonyms: HSMT3, SMT3 homolog 2, SMT3B, SMT3H2, SUMO-2, Sentrin-2, Small ubiquitin-related modifier 2, Ubiquitin-like protein SMT3B
-
Gen-ID
- 6613
-
NCBI Accession
- NP_001005849
-
UniProt
- P61956
-
Pathways
- Methionine Biosynthetic Process
Target
-